Some men with low testosterone might be tempted to hold off on treatment due to concerns about raised health risks. But for one common concern, those raised risks might not exist.

A newly approved drug may fight one of the most common types of skin cancer.

A first-in-its-class injectable cholesterol medication just received the US Food and Drug Administration's (FDA) seal of approval.

Sometimes it takes two. Two breast cancer medications, that is.

Anyone who has had one will probably say that passing kidney stones can be downright painful. In some cases, a medication used for another urinary problem could help with that problem.

Cancer patients may assume that the less radiation they need, the better. But that might not be the case for some.

Antibiotics are miracle drugs that have saved millions of lives, but some worry that their overuse could have serious consequences. Now there may be yet another cause for concern.

You may want to think twice before you down that bottle of Coke.

Sometimes important scientific discoveries occur secondhand. For Parkinson's disease, that may be exactly the case.

Weighing the benefits of medications against their potential risks is a common conundrum for many doctors. But, for one common diabetes medication, that decision may have gotten a little easier.